Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2018-02-03 00:34 2018-02-01 TDF TEMPLETON DRAGON FUND INC CITY OF LONDON INVESTMENT GROUP PLC 10% owner Other BUY $23.87 58,864 $1,405,084 58,864 +100.0%
2018-02-02 03:07 2018-01-30 SLDB Solid Biosciences Inc. Koppel Adam Director Biological Products, (No Diagnostic Substances) BUY $16.00 300,000 $4,800,000 1,989,444 +17.8%
2018-02-01 19:56 2018-01-30 TEI TEMPLETON EMERGING MARKETS INCOME FUND Saba Capital Management, L.P. 10% owner Other BUY $11.68 93,014 $1,085,966 6,071,036 +1.6%
2018-02-02 05:12 2018-01-30 BH N/A BIGLARI, SARDAR Director, 10% owner Other BUY $415.69 2,749 $1,142,744 702,104 +0.4%
2018-02-01 01:23 2018-01-29 RVLT N/A LAPENTA ROBERT V Director, Officer, 10% owner - Chairman and CEO Other BUY $3.60 850,000 $3,060,000 950,000 +850.0%
2018-01-31 02:37 2018-01-30 TORC Adicet Bio, Inc. PureTech Health LLC 10% owner Pharmaceutical Preparations BUY $15.00 233,333 $3,499,995 9,800,396 +2.4%
2018-01-31 01:43 2018-01-30 SLDB Solid Biosciences Inc. Shah Rajeev M. Director Biological Products, (No Diagnostic Substances) BUY $16.00 1,000,000 $16,000,000 2,689,444 +59.2%
2018-01-30 19:07 2018-01-26 TEI TEMPLETON EMERGING MARKETS INCOME FUND Saba Capital Management, L.P. 10% owner Other BUY $11.73 89,782 $1,052,757 5,933,831 +1.5%
2018-01-31 02:42 2018-01-30 TORC Adicet Bio, Inc. SILVERSTEIN JONATHAN Director, 10% owner Pharmaceutical Preparations BUY $15.00 533,333 $7,999,995 4,830,387 +12.4%
2018-01-30 21:05 2018-01-30 SLDB Solid Biosciences Inc. PERCEPTIVE ADVISORS LLC Director, 10% owner Biological Products, (No Diagnostic Substances) BUY $16.22 1,020,000 $16,546,542 3,927,222 +35.1%
2018-01-30 22:21 2018-01-05 CRSP CRISPR Therapeutics AG BAYER AKTIENGESELLSCHAFT 10% owner Biological Products, (No Diagnostic Substances) BUY $22.75 527,472 $11,999,988 5,632,802 +10.3%
2018-01-30 23:34 2018-01-26 KALA KALA BIO, Inc. ORBIMED ADVISORS LLC 10% owner Pharmaceutical Preparations BUY $14.97 72,760 $1,089,305 3,022,760 +2.5%
2018-01-31 02:41 2018-01-30 TORC Adicet Bio, Inc. ORBIMED ADVISORS LLC Director, 10% owner Pharmaceutical Preparations BUY $15.00 533,333 $7,999,995 4,830,387 +12.4%
2018-01-30 00:22 2018-01-25 MNLO VYNE Therapeutics Inc. venBio Global Strategic Fund II L.P. 10% owner Pharmaceutical Preparations BUY $17.00 265,000 $4,505,000 265,000 +100.0%
2018-01-30 00:19 2018-01-25 MNLO VYNE Therapeutics Inc. Remeditex Ventures LLC 10% owner Pharmaceutical Preparations BUY $17.00 100,000 $1,700,000 1,582,854 +6.7%
2018-01-30 00:17 2018-01-25 MNLO VYNE Therapeutics Inc. Vivo Capital VIII, LLC 10% owner Pharmaceutical Preparations BUY $17.00 294,118 $5,000,006 35,686 +100.0%
2018-01-30 00:14 2018-01-25 MNLO VYNE Therapeutics Inc. Cha Albert Director Pharmaceutical Preparations BUY $17.00 294,118 $5,000,006 35,686 +100.0%
2018-01-29 20:20 2018-01-26 LPG DORIAN LPG LTD. BW Group Ltd 10% owner Deep Sea Foreign Transportation of Freight BUY $7.39 1,826,460 $13,500,644 7,826,460 +30.4%
2018-01-30 04:41 2018-01-25 BH N/A BIGLARI, SARDAR Director, 10% owner Other BUY $416.30 2,840 $1,182,297 699,355 +0.4%
2018-01-30 01:01 2018-01-25 SAFE N/A ISTAR INC. 10% owner Other BUY $17.87 59,281 $1,059,624 7,257,810 +0.8%
2018-01-30 01:00 2018-01-22 SAFE N/A ISTAR INC. 10% owner Other BUY $17.82 65,053 $1,159,349 7,198,529 +0.9%
2018-01-26 23:32 2017-10-20 AMMA SCWorx Corp. Tracy Joel Daniel Director Services-Computer Processing & Data Preparation BUY $50,000.00 45,872 $2,293,600,000 320,574 +16.7%
2018-01-26 23:28 2017-10-20 AMMA SCWorx Corp. Gamberale Joseph Director Services-Computer Processing & Data Preparation BUY $240,000.00 220,183 $52,843,920,000 596,193 +58.6%
2018-01-26 22:30 2018-01-24 TEI TEMPLETON EMERGING MARKETS INCOME FUND Saba Capital Management, L.P. 10% owner Other BUY $11.77 116,500 $1,370,844 5,888,240 +2.0%
2018-01-26 23:30 2017-10-20 AMMA SCWorx Corp. SHEFTS MARK Director Services-Computer Processing & Data Preparation BUY $200,000.00 183,486 $36,697,200,000 373,763 +96.4%
2018-01-26 05:37 2018-01-19 COLD AMERICOLD REALTY TRUST Gross Bradley J. Director Real Estate Investment Trusts BUY $17.40 125,000 $2,175,000 125,000 +100.0%
2018-01-26 05:34 2018-01-19 COLD AMERICOLD REALTY TRUST GOLDMAN SACHS GROUP INC 10% owner Real Estate Investment Trusts BUY $17.40 125,000 $2,175,000 125,000 +100.0%
2018-01-26 05:35 2018-01-19 COLD AMERICOLD REALTY TRUST GS Advisors VI, L.L.C. 10% owner Real Estate Investment Trusts BUY $17.40 125,000 $2,175,000 125,000 +100.0%
2018-01-26 00:59 2018-01-25 ALBO N/A PERCEPTIVE ADVISORS LLC 10% owner Other BUY $33.00 275,000 $9,075,000 1,595,000 +20.8%
2018-01-24 21:05 2018-01-22 OCN ONITY GROUP INC. COOPERMAN LEON G 10% owner Mortgage Bankers & Loan Correspondents BUY $3.16 494,459 $1,561,502 5,640,468 +9.6%
2018-01-24 23:44 2018-01-22 TEI TEMPLETON EMERGING MARKETS INCOME FUND Saba Capital Management, L.P. 10% owner Other BUY $11.76 243,458 $2,862,409 5,771,740 +4.4%
2018-01-25 03:40 2018-01-22 BH N/A BIGLARI, SARDAR Director, 10% owner Other BUY $411.71 3,506 $1,443,446 696,515 +0.5%
2018-01-25 00:07 2018-01-22 SAFE N/A ISTAR INC. 10% owner Other BUY $17.81 65,053 $1,158,893 7,198,529 +0.9%
2018-01-25 04:59 2018-01-12 KALA KALA BIO, Inc. ORBIMED ADVISORS LLC 10% owner Pharmaceutical Preparations BUY $14.88 257,285 $3,828,993 2,950,000 +9.6%
2018-01-24 00:35 2018-01-23 AGIO Agios Pharmaceuticals Inc. CELGENE CORP /DE/ 10% owner Pharmaceutical Preparations BUY $67.00 851,154 $57,027,318 1,374,599 +162.6%
2018-01-22 17:48 2018-01-19 N-A N/A STRS OHIO 10% owner Other BUY $15.00 66,667 $1,000,000 601,446 +12.5%
2018-01-23 02:49 2018-01-18 BGFLX N/A Goodman Bennett J Other Other BUY $25.00 100,000 $2,500,000 100,000 +100.0%
2018-01-23 00:52 2018-01-18 ECR N/A EnCap Energy Capital Fund VIII, L.P. 10% owner Other BUY $2.44 37,823,596 $92,225,274 37,823,596 +100.0%
2018-01-22 17:04 2018-01-19 XON PRECIGEN, INC. KIRK RANDAL J Director, Officer, 10% owner - Chief Executive Officer Pharmaceutical Preparations BUY $12.50 1,000,000 $12,500,000 7,782,622 +14.7%
2018-01-23 01:03 2018-01-18 BGNE BeOne Medicines Ltd. BAKER BROS. ADVISORS LP Director, 10% owner Pharmaceutical Preparations BUY $101.00 1,980,198 $199,999,998 5,121,404 +63.0%
2018-01-20 03:47 2018-01-17 BH N/A BIGLARI, SARDAR Director, 10% owner Other BUY $416.84 3,471 $1,446,857 693,009 +0.5%
2018-01-20 00:16 2018-01-17 BLK N/A MAUGHAN DERYCK C Director Other BUY $573.44 3,861 $2,214,045 15,326 +33.7%
2018-01-20 01:19 2018-01-17 AQB AquaBounty Technologies Inc. KIRK RANDAL J 10% owner Fishing, Hunting and Trapping BUY $3.25 1,538,461 $4,999,998 6,700,738 +29.8%
2018-01-20 00:38 2018-01-17 PCF HIGH INCOME SECURITIES FUND Bulldog Investors, LLC 10% owner Other BUY $9.10 260,243 $2,368,081 1,526,215 +20.6%
2018-01-20 02:34 2018-01-17 S N/A SOFTBANK GROUP CORP 10% owner Other BUY $5.51 1,011,959 $5,575,894 3,390,794,559 +0.0%
2018-01-18 23:42 2017-12-11 N/A N/A Fortune Way Capital Corp (BVI) 10% owner Other BUY $15.00 83,333 $1,250,000 133,333 +166.7%
2018-01-18 19:04 2018-01-17 N/A Bain Capital Specialty Finance, Inc. Hough Thomas A. Director Other BUY $20,000.00 983 $19,656,000 4,929 +24.9%
2018-01-18 18:40 2018-01-17 N/A Bain Capital Specialty Finance, Inc. BAIN CAPITAL CREDIT MEMBER, LLC 10% owner Other BUY $53,221,587.70 2,615,311 $139,191,026,634,557 13,685,521 +23.6%
2018-01-18 19:22 2017-05-11 TDG TransDigm Group INC Skulina James Officer - Executive Vice President Aircraft Parts & Auxiliary Equipment, NEC BUY $243.85 6,422 $1,566,009 29,000 +28.4%
2018-01-18 19:08 2018-01-17 N/A Bain Capital Specialty Finance, Inc. MARGOLIS JAY Director Other BUY $25,000.00 1,229 $30,712,500 6,172 +24.9%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.